"Top 10 most influential" ITC trial lawyers, known for her "big wins"
Business Today, IAM Global 2023
"Lisa Kattan is a one-stop shop for any IP worries."
Chambers USA 2025
When fighting for the future of their business -- clients turn to Lisa Kattan. She knows that in order to outwit a global competitor, protect market share and safeguard supply chains -- her strategies must extend beyond the case at hand. Clients may be best served by decisive wins at the ITC, district court, or Customs, or by pivoting a business line or adjusting a product design. Lisa's ability to zero in on the most effective path to victory is why IAM 1000 described her as "an ace up the firm's sleeve" for ITC investigations, whose clients "turn to her without hesitation in complex cases" (2023).
Lisa has built her reputation as a fierce and unflappable advocate, and one of the country's preeminent ITC trial attorneys. Prior to Baker Botts, she spent five years as a Senior Investigative Attorney at the ITC, where she gained invaluable insights into the judges' perspectives. Lisa is "an excellent Section 337 attorney" (Chambers USA, 2025) whose arguments resonate and allow her to design laser-focused strategies that build credibility while simultaneously unraveling her opponent. Lisa can read the room -- whether a courtroom or a negotiation -- to get to the heart of the matter and help resolve disputes in her clients' favor.
Baker Botts' unparalleled string of victories at the ITC since Lisa joined the firm speaks for itself. These wins have been part of complex, multi-prong disputes spanning district courts, Customs, appeals, the PTAB, and foreign jurisdictions. During her years at the ITC, she was lead trial counsel for the U.S. Government in high-profile, multi-billion-dollar patent infringement investigations. Throughout her 25 year career, she has litigated patent and other intellectual property cases of telecommunications, chemical, pharmaceutical, medical device, and consumer products.
Lisa's ITC career began with Certain Modified Vaccinia Ankara and Vaccines and Pharmaceutical Compositions Based Thereon, ITC Investigation 337-TA-550. Throughout her 25-year career in the ITC and district courts around the country, she has litigated cases such as telecommunications hardware and communications standards; video streaming; polymer and CMP formulations; pharmaceuticals, including smallpox vaccine, antifungals, and hormone treatments; DNA sequencing; medical devices, including radiotherapy devices, CPAP devices, endotracheal tubes, and interocular lenses; and consumer products such as toner cartridges, beauty products, blenders, and flash memory devices.
Lisa is the firm's International Trade Commission Practice Group Chair and Chair of the Washington D.C. IP group. She is a recognized ITC practitioner in Chambers Global and Chambers USA (2018-2025) and IAM 1000 (2018-2025), and as a "Leading Lawyer" in The Legal 500 U.S. (2019-2025). She frequently speaks in the U.S. and Asia about patent litigation trends and best practices.
Won or successfully settled 18 of 20 ITC investigations in the last eight years, including:
Recognized as a "Leading Lawyer" by The Legal 500 U.S., 2020-2025
Recognized by Chambers USA, 2018-2025
Recognized by IAM Patent 1000: The World's Leading Patent Professionals, 2018-2025
Recognized by Business Today as one of the "Top 10 Most Influential Section 337 IP Lawyer in the USA," 2023
Recognized by The Best Lawyers in America (Woodward White, Inc.) for Litigation-Patent and International Trade and Finance Law, 2023-2025
